Literature DB >> 23466962

Long interspersed nuclear element ORF-1 protein promotes proliferation and resistance to chemotherapy in hepatocellular carcinoma.

Fan Feng1, Yin-Ying Lu, Fan Zhang, Xu-Dong Gao, Chuan-Fu Zhang, Alex Meredith, Zhong-Xian Xu, Yu-Tao Yang, Xiu-Juan Chang, Hong Wang, Jian-Hui Qu, Zhen Zeng, Jun-Lan Yang, Chun-Ping Wang, Yun-Feng Zhu, Jia-Jun Cui, Yong-Ping Yang.   

Abstract

AIM: To clarify the specific roles and mechanisms of long interspersed nuclear element-1 ORF-1 protein [human long interspersed nuclear element-1 (LINE-1), ORF-1p] in chemotherapeutic drug resistance and cell proliferation regulation in hepatocellular carcinoma (HCC) cells.
METHODS: MTT assays were performed to identify the effect of the chemotherapeutic drug toxicity on HepG2 cells. Cell proliferation inhibition and the IC50 were calculated by the Origin 8.0 software. Western blotting assays were performed to investigate whether LINE-1 ORF-1p modulates the expression of some important genes, including p53, p27, p15, Bcl-2, mdr, and p-gp. To corroborate the proliferation and anchor-independent growth results, the HepG2 cells were analyzed by flow cytometry to investigate the effect of LINE-1 ORF-1p on the apoptosis regulation.
RESULTS: LINE-1 ORF-1p contributed to the resistance to several chemotherapeutic drugs (cisplatin and epirubicin) in HepG2 cells. The IC50 of the epirubicin and cisplatin increased from 36.04 nmol/L to 59.11 nmol/L or from 37.94 nmol/L to 119.32 nmol/L. Repression of LINE-1 ORF-1p expression by the siRNA could markedly enhance the response of HepG2 cells to the epirubicin and cisplatin. The IC50 correspondingly decreased from 28.06 nmol/L to 3.83 nmol/L or from 32.04 nmol/L to 2.89 nmol/L. Interestingly, down-regulation of LINE-1 ORF-1p level by siRNA could promote the response of HepG2 cells to the paclitaxel. The IC50 decreased from 35.90 nmol/L to 7.36 nmol/L. However, overexpression of LINE-1 ORF-1p did not modulate the paclitaxel toxicity in HepG2 cells. Further Western blotting revealed that LINE-1 ORF-1p enhanced mdr and p-gp gene expression. As a protein arrested in the nucleus, LINE-1 ORF-1p may function through modulating transcriptional activity of some important transcription factors. Indeed, LINE-1 ORF-1p promoted HepG2 cell proliferation, anchor-independent growth and protected the cells against apoptosis through modulating the expression of p15, p21, p53, and Bcl-2 genes.
CONCLUSION: LINE-1 ORF-1p promotes HepG2 cell proliferation and plays an important role in the resistance of chemotherapeutic drugs. By establishing novel roles and defining the mechanisms of LINE-1 ORF-1p in HCC chemotherapeutic drug resistance and cell proliferation regulation, this study indicates that LINE-1 ORF-1p is a potential target for overcoming HCC chemotherapeutic resistance.

Entities:  

Keywords:  Chemotherapeutic drugs; Hepatocellular carcinoma; Long interspersed nuclear element-1 ORF-1 protein; Multi-drug resistance

Mesh:

Substances:

Year:  2013        PMID: 23466962      PMCID: PMC3581994          DOI: 10.3748/wjg.v19.i7.1068

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  17 in total

1.  CENP-E checks in microtubule-drug resistance.

Authors:  Chantal Chanel-Vos; Paraskevi Giannakakou
Journal:  Cell Cycle       Date:  2010-04-15       Impact factor: 4.534

2.  DNA modification with cisplatin affects sequence-specific DNA binding of p53 and p73 proteins in a target site-dependent manner.

Authors:  Hana Pivonková; Petr Pecinka; Pavla Cesková; Miroslav Fojta
Journal:  FEBS J       Date:  2006-09-18       Impact factor: 5.542

3.  Genetic predisposition of hand-foot skin reaction after sorafenib therapy in patients with hepatocellular carcinoma.

Authors:  Joo Ho Lee; Young-Hwa Chung; Jeong A Kim; Ju Hyun Shim; Danbi Lee; Han Chu Lee; Eun-Soon Shin; Jung Hwan Yoon; Byung Ik Kim; Si Hyun Bae; Kwang Cheol Koh; Neung-Hwa Park
Journal:  Cancer       Date:  2012-06-26       Impact factor: 6.860

4.  Neferine increases STI571 chemosensitivity via inhibition of P-gp expression in STI571-resistant K562 cells.

Authors:  Qun Qin; Xiao-Ping Chen; Zhou-Sheng Yang; Yu-Hang Xiao; Hui Min; Yuan-Jian Li
Journal:  Leuk Lymphoma       Date:  2011-01-24

5.  Pterostilbene and 3'-hydroxypterostilbene are effective apoptosis-inducing agents in MDR and BCR-ABL-expressing leukemia cells.

Authors:  Manlio Tolomeo; Stefania Grimaudo; Antonietta Di Cristina; Marinella Roberti; Daniela Pizzirani; Maria Meli; Luisa Dusonchet; Nicola Gebbia; Vincenzo Abbadessa; Lucia Crosta; Riccardo Barucchello; Giuseppina Grisolia; Francesco Invidiata; Daniele Simoni
Journal:  Int J Biochem Cell Biol       Date:  2005-04-26       Impact factor: 5.085

6.  Basal expression of the multidrug resistance gene 1 (MDR-1) is associated with the TT genotype at the polymorphic site C3435T in mammary and ovarian carcinoma cell lines.

Authors:  Georg Sauer; Ariane Kafka; Regina Grundmann; Rolf Kreienberg; Robert Zeillinger; Helmut Deissler
Journal:  Cancer Lett       Date:  2002-11-08       Impact factor: 8.679

7.  LINE-1 ORF1 protein localizes in stress granules with other RNA-binding proteins, including components of RNA interference RNA-induced silencing complex.

Authors:  John L Goodier; Lili Zhang; Melissa R Vetter; Haig H Kazazian
Journal:  Mol Cell Biol       Date:  2007-06-11       Impact factor: 4.272

8.  Proto-oncogene FBI-1 represses transcription of p21CIP1 by inhibition of transcription activation by p53 and Sp1.

Authors:  Won-Il Choi; Bu-Nam Jeon; Chae-Ok Yun; Pyung-Hwan Kim; Sung-Eun Kim; Kang-Yell Choi; Se Hoon Kim; Man-Wook Hur
Journal:  J Biol Chem       Date:  2009-02-25       Impact factor: 5.157

9.  Paired mutations abolish and restore the balanced annealing and melting activities of ORF1p that are required for LINE-1 retrotransposition.

Authors:  James D Evans; Suresh Peddigari; Kathy R Chaurasiya; Mark C Williams; Sandra L Martin
Journal:  Nucleic Acids Res       Date:  2011-03-26       Impact factor: 16.971

10.  LINE-1 hypomethylation during primary colon cancer progression.

Authors:  Eiji Sunami; Michiel de Maat; Anna Vu; Roderick R Turner; Dave S B Hoon
Journal:  PLoS One       Date:  2011-04-14       Impact factor: 3.240

View more
  14 in total

1.  Expression of microRNA-452 via adenoviral vector inhibits non-small cell lung cancer cells proliferation and metastasis.

Authors:  Yongsheng Zhang; Lu Han; Jian Pang; Yang Wang; Fan Feng; Qiyu Jiang
Journal:  Tumour Biol       Date:  2015-12-30

2.  A High Throughput Cell-Based Screen Assay for LINE-1 ORF1p Expression Inhibitors Using the In-Cell Western Technique.

Authors:  Yanni Kou; Shujie Wang; Yanjie Ma; Ning Zhang; Zixiong Zhang; Qian Liu; Yang Mao; Rui Zhou; Dongrong Yi; Ling Ma; Yongxin Zhang; Quanjie Li; Jing Wang; Jinhui Wang; Xile Zhou; Chunnian He; Jiwei Ding; Shan Cen; Xiaoyu Li
Journal:  Front Pharmacol       Date:  2022-05-24       Impact factor: 5.988

3.  Novel mTOR Inhibitor Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Molecular Targeting Agents.

Authors:  Ying-Qi Feng; Bo-An Li; Fan Feng; Yong-Shou Chen; Yi-Xin Ren; Heng Zhang; Shuang Cao
Journal:  Onco Targets Ther       Date:  2020-07-27       Impact factor: 4.147

4.  Estrogen receptor α enhances the transcriptional activity of ETS-1 and promotes the proliferation, migration and invasion of neuroblastoma cell in a ligand dependent manner.

Authors:  Peng Cao; Fan Feng; Guofu Dong; Chunyong Yu; Sizhe Feng; Erlin Song; Guobing Shi; Yong Liang; Guobiao Liang
Journal:  BMC Cancer       Date:  2015-06-30       Impact factor: 4.430

5.  Expression of microRNA-30c via lentivirus vector inhibits the proliferation and enhances the sensitivity of highly aggressive ccRCC Caki-1 cells to anticancer agents.

Authors:  Honglin Yang; Erlin Song; Guorong Shen; Tonghua Zhu; Tingwang Jiang; Hao Shen; Liping Niu; Biao Wang; Zhaoyang Lu; Jianping Qian
Journal:  Onco Targets Ther       Date:  2017-02-02       Impact factor: 4.147

6.  APOBEC3B Activity Is Prevalent in Urothelial Carcinoma Cells and Only Slightly Affected by LINE-1 Expression.

Authors:  Ananda Ayyappan Jaguva Vasudevan; Ulrike Kreimer; Wolfgang A Schulz; Aikaterini Krikoni; Gerald G Schumann; Dieter Häussinger; Carsten Münk; Wolfgang Goering
Journal:  Front Microbiol       Date:  2018-09-04       Impact factor: 5.640

7.  Silencing the expression of copine-III enhances the sensitivity of hepatocellular carcinoma cells to the molecular targeted agent sorafenib.

Authors:  Zhuo Chen; Zhengkui Jiang; Wenzhou Zhang; Baoxia He
Journal:  Cancer Manag Res       Date:  2018-08-29       Impact factor: 3.989

8.  MicroRNA-140-3p enhances the sensitivity of hepatocellular carcinoma cells to sorafenib by targeting pregnenolone X receptor.

Authors:  Jiaqi Li; Jing Zhao; Huan Wang; Xiaohan Li; Aixia Liu; Qin Qin; Boan Li
Journal:  Onco Targets Ther       Date:  2018-09-17       Impact factor: 4.147

9.  miR-122 inhibits metastasis and epithelial-mesenchymal transition of non-small-cell lung cancer cells.

Authors:  Haifeng Qin; Jiping Sha; Caixia Jiang; Xuemei Gao; Lili Qu; Haiying Yan; Tianjiao Xu; Qiyu Jiang; Hongjun Gao
Journal:  Onco Targets Ther       Date:  2015-10-29       Impact factor: 4.147

10.  LINE-1 ORF-1p enhances the transcription factor activity of pregnenolone X receptor and promotes sorafenib resistance in hepatocellular carcinoma cells.

Authors:  Yan Chen; Qinglei Zeng; Xiufang Liu; Junliang Fu; Zhen Zeng; Zhiqin Zhao; Ze Liu; Wenlin Bai; Zheng Dong; Hongjin Liu; Xiaoxia Lu; Yunfeng Zhu; Yinying Lu
Journal:  Cancer Manag Res       Date:  2018-10-10       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.